Published in Toxicol Appl Pharmacol on November 01, 1990
Measurement of vitamin D3 metabolites in smelter workers exposed to lead and cadmium. Occup Environ Med (1998) 1.49
Spatial distribution of the trace elements zinc, strontium and lead in human bone tissue. Bone (2013) 0.94
Associations of bone mineral density and lead levels in blood, tibia, and patella in urban-dwelling women. Environ Health Perspect (2008) 0.89
The effect of lead on bone mineral properties from female adult C57/BL6 mice. Bone (2010) 0.88
Allogeneic and Autogenous Bone Grafts Are Affected by Historical Donor Environmental Exposure. Clin Orthop Relat Res (2016) 0.75
Declining blood lead levels and cognitive changes in moderately lead-poisoned children. JAMA (1993) 4.46
Osteocalcin in human serum: a circadian rhythm. J Clin Endocrinol Metab (1985) 1.81
Cellular and molecular toxicity of lead in bone. Environ Health Perspect (1991) 1.80
Low-level lead-induced neurotoxicity in children: an update on central nervous system effects. Brain Res Brain Res Rev (1998) 1.61
Effect of lead intoxication on calcium homeostasis and calcium-mediated cell function: a review. Neurotoxicology (1984) 1.42
Primary prevention of childhood lead poisoning--the only solution. N Engl J Med (2001) 1.39
25-Hydroxyvitamin D. Plasma levels in mothers and their premature infants with neonatal hypocalcemia. Am J Dis Child (1974) 1.35
Reduction in 1,25-dihydroxyvitamin D in children with increased lead absorption. N Engl J Med (1980) 1.34
Absence of seasonal variation in serum concentrations of 1,25-dihydroxyvitamin D despite a rise in 25-hydroxyvitamin D in summer. J Clin Endocrinol Metab (1981) 1.32
Health effects of lead at low exposure levels. Expert consensus and rationale for lowering the definition of childhood lead poisoning. Am J Dis Child (1992) 1.31
Rickets with alopecia: an inborn error of vitamin D metabolism. J Pediatr (1979) 1.27
Basal ganglia calcification (BGC) in Down's syndrome (DS)--another manifestation of premature aging. Ann N Y Acad Sci (1982) 1.26
Association between age, blood lead concentration, and serum 1,25-dihydroxycholecalciferol levels in children. Am J Clin Nutr (1982) 1.26
Feasibility of noninvasive analysis of lead in the human tibia by soft x-ray fluorescence. Med Phys (1983) 1.25
1,25-Dihydroxycholecalciferol: its use in the long-term management of idiopathic hypoparathyroidism in children. J Clin Endocrinol Metab (1977) 1.18
Management of childhood lead poisoning. J Pediatr (1984) 1.17
The effect of Pb(2+) on the structure and hydroxyapatite binding properties of osteocalcin. Biochim Biophys Acta (2001) 1.14
A cellular defect in hereditary vitamin-D-dependent rickets type II: defective nuclear uptake of 1,25-dihydroxyvitamin D in cultured skin fibroblasts. N Engl J Med (1981) 1.14
Relationships among blood lead levels, iron deficiency, and cognitive development in two-year-old children. Environ Health Perspect (1996) 1.13
The effects of Clostridium perfringens enterotoxin on rat and rabbit ileum: an electron microscopic study. Lab Invest (1978) 1.08
Marrow transplantation for juvenile osteopetrosis. Am J Med (1981) 1.07
Circadian rhythms of blood minerals in humans. Science (1981) 1.05
Vitamin D-dependent rickets: actions of parathyroid hormone and 25-hydroxycholecalciferol. Pediatr Res (1972) 1.05
The microdetermination of blood lead in children by flameless atomic absorption: the carbon rod atomizer. J Lab Clin Med (1972) 1.04
Interactions of lead, calcium, vitamin D, and nutrition in lead-burdened children. Arch Environ Health (1977) 1.02
Lead increases free Ca2+ concentration in cultured osteoblastic bone cells: simultaneous detection of intracellular free Pb2+ by 19F NMR. Proc Natl Acad Sci U S A (1989) 1.00
Lead intoxication alters basal and parathyroid hormone-regulated cellular calcium homeostasis in rat osteosarcoma (ROS 17/2.8) cells. Calcif Tissue Int (1992) 1.00
Estimation of cumulative lead releases (lead flux) from the maternal skeleton during pregnancy and lactation. J Lab Clin Med (1999) 0.99
In vivo measurement of cortical bone lead using polarized x rays. Med Phys (1989) 0.99
The three-dimensional structure of bovine calcium ion-bound osteocalcin using 1H NMR spectroscopy. Biochemistry (2003) 0.98
Need for the lead mobilization test in children with lead poisoning. J Pediatr (1991) 0.98
Serum 1,25-dihydroxyvitamin D levels in normal children and in vitamin D disorders. Am J Dis Child (1980) 0.97
Lead activation of protein kinase C from rat brain. Determination of free calcium, lead, and zinc by 19F NMR. J Biol Chem (1994) 0.97
Effect of lead on calcium homeostasis in the isolated rat hepatocyte. Toxicol Appl Pharmacol (1982) 0.97
Childhood lead poisoning in China. Sci Total Environ (1996) 0.96
Role of nuclear analytical probe techniques in biological trace-element research. Biol Trace Elem Res (1987) 0.96
Significance of plasma lead levels in normal and lead-intoxicated children. Environ Health Perspect (1974) 0.95
Preparation and Characterization Challenges to Understanding Environmental and Biological Impacts of Nanoparticles. Surf Interface Anal (2012) 0.94
Effects of iron deficiency on lead excretion in children with moderate lead intoxication. J Pediatr (1990) 0.94
The metabolism of lead in isolated bone cell populations: interactions between lead and calcium. Toxicol Appl Pharmacol (1983) 0.94
Chemical mixtures from a public health perspective: the importance of research for informed decision making. Toxicology (1995) 0.94
Immobilization hypercalcemia after single limb fractures in children and adolescents. Am J Dis Child (1978) 0.92
Circadian variations in serum zinc (Zn) concentrations: correlation with blood ionized calcium, serum total calcium and phosphate in humans. Am J Clin Nutr (1985) 0.92
Sensitivity of myelomonocytic leukemia cells to arsenite-induced cell cycle disruption, apoptosis, and enhanced differentiation is dependent on the inter-relationship between arsenic concentration, duration of treatment, and cell cycle phase. J Pharmacol Exp Ther (2000) 0.91
Quantitative interactions between Pb2+ and Ca2+ homeostasis in cultured osteoclastic bone cells. Toxicol Appl Pharmacol (1989) 0.91
The circadian rhythm of serum osteocalcin concentrations: effects of 1,25 dihydroxyvitamin D administration. Calcif Tissue Int (1987) 0.90
Cellular metabolism of lead: a kinetic analysis in cultured osteoclastic bone cells. Toxicol Appl Pharmacol (1986) 0.89
Assessment of lead stores in children: validation of an 8-hour CaNa2EDTA provocative test. J Pediatr (1984) 0.88
The effects of succimer on the absorption of lead in adults determined by using the stable isotope 204Pb. Environ Res (1994) 0.88
The displacement of calcium from osteocalcin at submicromolar concentrations of free lead. Biochim Biophys Acta (1994) 0.88
Maternal and fetal serum 1,25-dihydroxyvitamin D levels at term. J Pediatr (1980) 0.87
Lead perturbs epidermal growth factor (EGF) modulation of intracellular calcium metabolism and collagen synthesis in clonal rat osteoblastic (ROS 17/2.8) cells. Toxicol Appl Pharmacol (1992) 0.87
X-ray fluorescence with synchrotron radiation. Ultramicroscopy (1988) 0.86
Effects of calcium disodium versenate (CaNa2EDTA) chelation in moderate childhood lead poisoning. Pediatrics (1993) 0.86
31P NMR and saturation transfer studies of the effect of Pb2+ on cultured osteoblastic bone cells. J Biol Chem (1990) 0.86
25-Hydroxycholecalciferol inthe management of rickets associated with extrahepatic biliary atresia. J Pediatr (1976) 0.85
Parathyroid adenoma, parathyroid crisis, and acute pancreatitis in an adolescent. J Pediatr (1973) 0.85
Radiation risk to the human conceptus from measurement of maternal tibial bone lead by L-line x-ray fluorescence. Health Phys (1990) 0.85
Effect of lead on calcium-mediated cell function in the isolated rat hepatocyte. Toxicol Appl Pharmacol (1982) 0.85
Cellular lead toxicity and metabolism in primary and clonal osteoblastic bone cells. Toxicol Appl Pharmacol (1990) 0.85
Temporal interrelationships between the circadian rhythms of serum parathyroid hormone and calcium concentrations. J Clin Endocrinol Metab (1988) 0.84
Effect of lead on parathyroid hormone-induced responses in rat osteoblastic osteosarcoma cells (ROS 17/2.8) using 19F-NMR. Biochim Biophys Acta (1990) 0.84
Development of 19F NMR for measurement of [Ca2+]i and [Pb2+]i in cultured osteoblastic bone cells. Environ Health Perspect (1990) 0.84
Circadian rhythms of blood minerals during adolescence. Pediatr Res (1984) 0.83
Cellular Ca2+ homeostasis and Ca2+-mediated cell processes as critical targets for toxicant action: conceptual and methodological pitfalls. Toxicol Appl Pharmacol (1988) 0.83
Lead inhibits 1,25-dihydroxyvitamin D-3 regulation of calcium metabolism in osteoblastic osteosarcoma cells (ROS 17/2.8). Biochim Biophys Acta (1992) 0.83
Effects of 1,25 dihydroxyvitamin D3 administration on circadian mineral rhythms in humans. Calcif Tissue Int (1985) 0.83
Metabolism of lead-210 in juvenile and adult rhesus monkeys (Macaca mulatta). Bull Environ Contam Toxicol (1978) 0.83
1,25-dihydroxyvitamin D3-treated hypoparathyroidism: 35 patients years in 10 children. J Clin Endocrinol Metab (1982) 0.82
Calcitonin in metabolic disorders. Adv Metab Disord (1972) 0.81
Children with moderately elevated blood lead levels: a role for other diagnostic tests? Environ Health Perspect (1997) 0.81
Cellular metabolism of lead: a kinetic analysis in the isolated rat hepatocyte. Toxicol Appl Pharmacol (1982) 0.81
Lead induced rise in intracellular free calcium is mediated through activation of protein kinase C in osteoblastic bone cells. Biochim Biophys Acta (1997) 0.80
Effects of low levels of lead exposure. Science (1992) 0.80
The goal: safety and equality. Am J Ind Med (1992) 0.80
Studies of lead transport in bone organ culture. Biochem Pharmacol (1977) 0.80
Problems in determination of skeletal lead burden in archaeological samples: an example from the First African Baptist Church population. Am J Phys Anthropol (2008) 0.79
Distribution of trace levels of therapeutic gallium in bone as mapped by synchrotron x-ray microscopy. Proc Natl Acad Sci U S A (1990) 0.79
A nonlinear isobologram model with Box-Cox transformation to both sides for chemical mixtures. Environ Health Perspect (1998) 0.79
"Severe chronic lead insult that maintains body burdens of lead related to those in the skeleton": observations by Dr. Clair Patterson conclusively demonstrated. Environ Res (1998) 0.79
Mobilization of cellular calcium-45 and lead-210: effect of physiological stimuli. Science (1983) 0.79
Moderate lead poisoning: trends in blood lead levels in unchelated children. Environ Health Perspect (1996) 0.79
Circulating calcitriol concentrations in health and disease. J Pediatr (1983) 0.79
Potentiation of dimethylnitrosamine genotoxicity in rat hepatocytes isolated following ethanol treatment in vivo. Chem Biol Interact (1984) 0.78
Ionized calcium: serum levels during symptomatic hypocalcemia. J Pediatr (1975) 0.78
Serial measurements of aminolevulinic acid dehydratase in children with lead toxicity. J Pediatr (1988) 0.78
D-penicillamine: its actions on lead transport in bone organ culture. Pediatr Res (1980) 0.77
Depressed excretion of 6 beta-hydroxycortisol in lead-toxic children. J Clin Endocrinol Metab (1984) 0.77
Effect of dietary calcium and lead status on intestinal calcium absorption. Environ Res (1990) 0.77
Blood collection and analytical considerations in blood lead screening in children. Clin Chem (1995) 0.77
Lead inhibits meso-2,3-dimercaptosuccinic acid induced calcium transients in cultured rhesus monkey kidney cells. Toxicology (1999) 0.77
Prenatal and neonatal toxicology and pathology of heavy metals. Adv Pharmacol Chemother (1980) 0.77
Potentiation of chlorinated hydrocarbon toxicity by 2,5-hexanedione in primary cultures of adult rat hepatocytes. Fundam Appl Toxicol (1983) 0.76
Hereditary resistance to 1,25-dihydroxyvitamin D: defective function of receptors for 1,25-dihydroxyvitamin D in cells cultured from bone. J Clin Endocrinol Metab (1983) 0.76
Blood lead levels in children. CMAJ (1993) 0.76
Subcellular distribution of lead in cultured rat hepatocytes. Environ Res (1984) 0.76